BNTX - BNTX NEWS: Johnson Fistel Encourages BioNTech Investors to Seek Counsel Before the Lead Plaintiff Deadline | Benzinga
SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP notifies investors of BioNTech SE (NASDAQ:BNTX) that a securities class action lawsuit has been filed.
The class action against BioNTech includes allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) BioNTech overstated demand for and/or the commercial prospects of Comirnaty, the COVID-19 vaccine developed by the Company in collaboration with Pfizer ; (ii) the Company and/or Pfizer had accumulated excess inventory of raw materials for Comirnaty, as well as COVID-19 vaccine doses adapted to other, non-XBB.1.5 variants that were produced at risk; (iii) accordingly, BioNTech was at an increased risk of recording significant inventory write-offs and other charges related to Comirnaty; and (iv) as ...